These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 15840865)

  • 21. The safety of intravenous diuretics alone versus diuretics plus parenteral vasoactive therapies in hospitalized patients with acutely decompensated heart failure: a propensity score and instrumental variable analysis using the Acutely Decompensated Heart Failure National Registry (ADHERE) database.
    Costanzo MR; Johannes RS; Pine M; Gupta V; Saltzberg M; Hay J; Yancy CW; Fonarow GC
    Am Heart J; 2007 Aug; 154(2):267-77. PubMed ID: 17643575
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety and efficacy of nesiritide for the treatment of decompensated heart failure.
    Emerman CL
    Rev Cardiovasc Med; 2002; 3 Suppl 4():S28-34. PubMed ID: 12439428
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circulating Kidney Injury Molecule-1 Levels in Acute Heart Failure: Insights From the ASCEND-HF Trial (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure).
    Grodin JL; Perez AL; Wu Y; Hernandez AF; Butler J; Metra M; Felker GM; Voors AA; McMurray JJ; Armstrong PW; Califf RM; Starling RC; O'Connor CM; Tang WH
    JACC Heart Fail; 2015 Oct; 3(10):777-85. PubMed ID: 26449997
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of nesiritide and predictors of urine output in acute decompensated heart failure: results from ASCEND-HF (acute study of clinical effectiveness of nesiritide and decompensated heart failure).
    Gottlieb SS; Stebbins A; Voors AA; Hasselblad V; Ezekowitz JA; Califf RM; O'Connor CM; Starling RC; Hernandez AF
    J Am Coll Cardiol; 2013 Sep; 62(13):1177-83. PubMed ID: 23747790
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcomes associated with vasoactive therapy in patients with acute decompensated heart failure.
    Arnold LM; Crouch MA; Carroll NV; Oinonen MJ
    Pharmacotherapy; 2006 Aug; 26(8):1078-85. PubMed ID: 16863484
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nesiritide, renal function, and associated outcomes during hospitalization for acute decompensated heart failure: results from the Acute Study of Clinical Effectiveness of Nesiritide and Decompensated Heart Failure (ASCEND-HF).
    van Deursen VM; Hernandez AF; Stebbins A; Hasselblad V; Ezekowitz JA; Califf RM; Gottlieb SS; O'Connor CM; Starling RC; Tang WH; McMurray JJ; Dickstein K; Voors AA
    Circulation; 2014 Sep; 130(12):958-65. PubMed ID: 25074507
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacoeconomic modeling of nesiritide versus dobutamine for decompensated heart failure.
    Gerhard T; Zineh I; Winterstein AG; Hartzema AG
    Pharmacotherapy; 2006 Jan; 26(1):34-43. PubMed ID: 16509026
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Natriuretic peptides for the treatment of acute heart failure: a focus on nesiritide in recent clinical trials.
    Fajardo J; Heywood JT; Patterson JH; Adams K; Chow SL
    Expert Rev Cardiovasc Ther; 2015; 13(7):743-51. PubMed ID: 26028173
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of nesiritide (B-type natriuretic peptide) and dobutamine on ventricular arrhythmias in the treatment of patients with acutely decompensated congestive heart failure: the PRECEDENT study.
    Burger AJ; Horton DP; LeJemtel T; Ghali JK; Torre G; Dennish G; Koren M; Dinerman J; Silver M; Cheng ML; Elkayam U;
    Am Heart J; 2002 Dec; 144(6):1102-8. PubMed ID: 12486437
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Benefit-risk assessment of nesiritide in the treatment of acute decompensated heart failure.
    Yancy CW
    Drug Saf; 2007; 30(9):765-81. PubMed ID: 17722969
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nesiritide for acute decompensated heart failure: does the benefit justify the risk?
    Sackner-Bernstein J; Aaronson KD
    Curr Cardiol Rep; 2007 May; 9(3):187-93. PubMed ID: 17470331
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Controversy and conflict in the treatment of acute decompensated heart failure: limited role for nesiritide.
    Noviasky JA
    Pharmacotherapy; 2007 May; 27(5):626-32. PubMed ID: 17461696
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety and efficacy of nesiritide for acute decompensated heart failure: recent literature and upcoming trials.
    Hiestand B; Abraham WT
    Curr Cardiol Rep; 2007 May; 9(3):182-6. PubMed ID: 17470330
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of nesiritide infusion duration on renal function in acutely decompensated heart failure patients.
    Chow SL; Peng JT; Okamoto MP; Heywood JT
    Ann Pharmacother; 2007 Apr; 41(4):556-61. PubMed ID: 17389662
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Nesiritide, a novel treatment for heart failure].
    Francisco-Méndez G
    Rev Med Inst Mex Seguro Soc; 2007; 45(3):281-9. PubMed ID: 17692167
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nesiritide does not improve renal function in patients with chronic heart failure and worsening serum creatinine.
    Wang DJ; Dowling TC; Meadows D; Ayala T; Marshall J; Minshall S; Greenberg N; Thattassery E; Fisher ML; Rao K; Gottlieb SS
    Circulation; 2004 Sep; 110(12):1620-5. PubMed ID: 15337695
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nesiritide--not verified.
    Schreiner G
    N Engl J Med; 2005 Oct; 353(14):1525-7; author reply 1525-7. PubMed ID: 16211709
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical and hemodynamic effects of nesiritide (B-type natriuretic peptide) in patients with decompensated heart failure receiving beta blockers.
    Abraham WT; Cheng ML; Smoluk G;
    Congest Heart Fail; 2005; 11(2):59-64. PubMed ID: 15860969
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of nesiritide before and after publications suggesting drug-related risks in patients with acute decompensated heart failure.
    Hauptman PJ; Schnitzler MA; Swindle J; Burroughs TE
    JAMA; 2006 Oct; 296(15):1877-84. PubMed ID: 17047218
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Observation unit treatment of heart failure with nesiritide: results from the proaction trial.
    Peacock WF; Holland R; Gyarmathy R; Dunbar L; Klapholz M; Horton DP; de Lissovoy G; Emerman CL
    J Emerg Med; 2005 Oct; 29(3):243-52. PubMed ID: 16183441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.